NextGen Immuno Therapeutics signifies a future-driven company dedicated to revolutionizing immune-related disease treatments using advanced technologies such as AI, multi-omics, and precision medicine. It conveys a commitment to developing next-generation Therapeutic options for conditions like GVHD, transplant rejection, autoimmune disorders, cancer immunotherapy, and infectious diseases.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Nippongasse, 8,austria
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.nextgenimmuno.com
- Keywords
- Catherinn BV.
- HQ
- Vienna, Vienna
Nextgen Immuno Therapeutics Questions
Nextgen Immuno Therapeutics's website is http://www.nextgenimmuno.com
Nextgen Immuno Therapeutics's LinkedIn profile is https://at.linkedin.com/company/nextgenimmuno
Nextgen Immuno Therapeutics has
1 employees.
View email and phone details for 1
employees at Nextgen Immuno Therapeutics.
Nextgen Immuno Therapeutics's industry is
Hospitals and Health Care
Nextgen Immuno Therapeutics's top competitors are
Cicon - International Cancer Immunotherapy Conference,
Viratherapeutics Gmbh,
Harrer & Partner Unternehmensberatung,
Gründerio,
Maptimmune,
Pantarhei Oncology B.v.,
Cimaas Bv,
Cast H2020,
Imagine!,
Catherinn Bv.
Nextgen Immuno Therapeutics's categories are Hospitals and Health Care
Nextgen Immuno Therapeutics's founding year is 2025
